δ-phase manganese dioxide nanoplatelet dispersions (MnO₂) provide optimized electrochemical activity, superior conductivity, and enhanced catalytic efficiency. Designed for energy storage, sensors, and environmental applications, they ensure efficient charge transfer, extended stability, and high adaptability.
Product Overview
δ-phase Manganese Dioxide (MnO₂) with a unique flower-like structure is a specialized manganese oxide material that exhibits a three-dimensional petal arrangement. This structure effectively prevents the aggregation of nanoplatelets, offering a high surface area and excellent biocompatibility. Under mildly acidic conditions, δ-phase MnO₂ reacts with glutathione (GSH), a metabolic product of cancer cells, leading to the generation of Mn²⁺ and serving as a contrast agent for magnetic resonance imaging (MRI). Additionally, δ-phase MnO₂ acts as a catalyst in tumor treatment by decomposing hydrogen peroxide and releasing oxygen, which alleviates hypoxic conditions within tumors.
Key Features
- Crystal Structure: The δ-phase MnO₂ features a 2D layered nanostructure with a low cost and high surface area, contributing to superior performance in various applications.
- Electrochemical Performance: Its unique crystal structure endows δ-phase MnO₂ with excellent capacitive properties and good cycle stability, making it suitable for use in supercapacitors and batteries.
- Morphological Advantage: The flower-like structure enhances the surface area, improving ion and electron transport efficiency, which in turn enhances electrochemical performance.
Applications
- Supercapacitors: Due to its excellent capacitive properties and cycle stability, δ-phase MnO₂ is ideal as a positive electrode material for supercapacitors.
- Battery Materials: It can be used as an electrode material or additive in batteries to improve their performance and stability.
- Other Applications: δ-phase MnO₂ also shows potential in water treatment, catalysis, sensors, and biomedical applications, particularly in environmental and cancer treatment fields.
Parameter | Description |
Name | δ-phase flower-like manganese dioxide dispersion |
Diameter | 200-600 nm (TEM) |
Concentration | 0.5 mg/mL, 1 mg/mL |
Main component | δ-MnO₂ |
Appearance | Gray-black solution |
Solvent | Water |